Lymphomas can affect any organ in the body, present with a wide range of symptoms, and
be seen by primary care physicians and physicians from most specialties. They are …

Cancer cells can escape T-cell-mediated cellular cytotoxicity by exploiting the inhibitory
programmed cell-death protein 1 (PD-1)/programmed cell death 1 ligand 1 (PD-L1) immune …

PURPOSE Alliance/CALGB 50303 (NCT00118209), an intergroup, phase III study,
compared dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide …

Purpose Recent advances in imaging, use of prognostic indices, and molecular profiling
techniques have the potential to improve disease characterization and outcomes in …

PURPOSE Primary mediastinal B-cell lymphoma (PMBL) is a rare but aggressive non-
Hodgkin lymphoma with poor outcomes in patients with relapsed/refractory (R/R) disease …

PURPOSE Patients with relapsed or refractory primary mediastinal large B-cell lymphoma
(rrPMBCL) have a poor prognosis, and their treatment represents an urgent and unmet …

Diffuse large B-cell lymphoma (DLBCL) is an aggressive B-cell non-Hodgkin lymphoma that
affects patients of all ages with a wide range of clinical presentations. Although DLBCL is …

Background Diffuse large-B-cell lymphoma is curable, but when treatment fails, outcome is
poor. Although imaging can help to identify patients at risk of treatment failure, they are often …

Non-Hodgkin lymphoma is the fourth most common malignancy in children, has an even
higher incidence in adolescents, and is primarily represented by only a few histologic …

Background Burkitt's lymphoma is an aggressive B-cell lymphoma that occurs in children
and adults and is largely curable with the use of intensive and toxic chemotherapy. Current …